In the current study, we demonstrated dynamic changes in p300 expression in pancreatic cancer cells upon exposure to gemcitabine and suggested that p300 may contribute to pancreatic cancer chemo-resistance by protecting cells from gemcitabine-induced apoptosis. Here, EP300 is linked to pancreatic neoplasm.